ArticleBMC cancer2012

Synthetic lethal screen identifies NF-κB as a target for combination therapy with topotecan for patients with neuroblastoma.

Patricia S Tsang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.